Pricing Log in Create free account

Codexis, Inc. (CDXS) vs Immunic, Inc. (IMUX)

Codexis, Inc. and Immunic, Inc. are both Biotechnology companies. Codexis, Inc. and Immunic, Inc. are of similar size ($109.7M and $109.5M). Immunic, Inc. has the higher net margin (0.00% vs −39.6%) and the higher return on invested capital (0.00% vs −151.2%). Across the 14 metrics below, Codexis, Inc. leads on 7 and Immunic, Inc. on 7.

Valuation

Metric CDXS IMUX Biotechnology median
P/E n/m n/m 11.58
P/S 1.14 n/m 9.61
P/B 2.68 2.72 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales 0.86 n/m 9.43
Earnings yield (35.05%) (53.68%) (32.28%)
Free cash flow yield (13.77%) (25.38%) (22.27%)

Profitability

Metric CDXS IMUX Biotechnology median
Gross margin 87.02% 0.00% 68.81%
Operating margin (35.61%) 0.00% 0.00%
Net margin (39.55%) 0.00% 0.00%
Free cash flow margin (15.66%) 0.00% 0.00%
Return on equity (69.36%) (138.17%) (50.30%)
Return on assets (23.79%) (101.15%) (45.47%)
Return on invested capital (151.17%) 0.00% 0.00%

Growth

Metric CDXS IMUX Biotechnology median
Revenue growth (TTM) 35.89% — 6.78%
EPS growth (last fiscal year) 43.82% 38.00% 29.88%
Revenue growth, 5-year CAGR 0.38% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CDXS IMUX Biotechnology median
Debt to equity 1.03 0.00 0.00
Current ratio 3.06 5.05 4.74
Net debt to EBITDA 1.11 0.15 1.01

Dividend

Metric CDXS IMUX Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric CDXS IMUX Biotechnology median
Market cap 109.50m 109.70m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack